ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hydroxyprogesterone Caproate Injection Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-5U2673
Home | Market Reports | Health| Pharmacy
Global Hydroxyprogesterone Caproate Injection Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Hydroxyprogesterone Caproate Injection Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-5U2673
Report
June 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V.
American Regent, Inc
Mylan Institutional

Hydroxyprogesterone Caproate Injection Market Size

In 2024, the global market size of Hydroxyprogesterone Caproate Injection was estimated to be worth US$ 271 million and is forecast to reach approximately US$ 300 million by 2031 with a CAGR of 1.5% during the forecast period 2025-2031.

Hydroxyprogesterone Caproate Injection Market

Hydroxyprogesterone Caproate Injection Market

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hydroxyprogesterone Caproate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyprogesterone Caproate Injection.
The Hydroxyprogesterone Caproate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hydroxyprogesterone Caproate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydroxyprogesterone Caproate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Hydroxyprogesterone Caproate Injection Market Report

Report Metric Details
Report Name Hydroxyprogesterone Caproate Injection Market
Forecasted market size in 2031 approximately US$ 300 million
CAGR 1.5%
Forecasted years 2025 - 2031
Segment by Type
  • 1 mL Injection(Including 1.1 mL)
  • 5 mL Injection
Segment by Application
  • Hospitals Injection
  • Clinics Injection
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AMAG Pharmaceuticals, Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., Mylan Institutional
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Hydroxyprogesterone Caproate Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hydroxyprogesterone Caproate Injection sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Hydroxyprogesterone Caproate Injection Market size in 2031?

Ans: The Hydroxyprogesterone Caproate Injection Market size in 2031 will be approximately US$ 300 million.

What is the AMAG Pharmaceuticals share in Hydroxyprogesterone Caproate Injection Market?

Ans: Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market.

What is the Hydroxyprogesterone Caproate Injection Market share by region?

Ans: North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%.

What is the Hydroxyprogesterone Caproate Injection Market share by type?

Ans: The most common product is 5 ml injection, with a share over 52%.

Who are the main players in the Hydroxyprogesterone Caproate Injection Market report?

Ans: The main players in the Hydroxyprogesterone Caproate Injection Market are AMAG Pharmaceuticals, Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., Mylan Institutional

What are the Application segmentation covered in the Hydroxyprogesterone Caproate Injection Market report?

Ans: The Applications covered in the Hydroxyprogesterone Caproate Injection Market report are Hospitals Injection, Clinics Injection

What are the Type segmentation covered in the Hydroxyprogesterone Caproate Injection Market report?

Ans: The Types covered in the Hydroxyprogesterone Caproate Injection Market report are 1 mL Injection(Including 1.1 mL), 5 mL Injection

Recommended Reports

Gynecological Treatments

Hormone APIs and Pharmaceuticals

Steroid and Corticosteroid Markets

1 Study Coverage
1.1 Hydroxyprogesterone Caproate Injection Product Introduction
1.2 Market by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 1 mL Injection(Including 1.1 mL)
1.2.3 5 mL Injection
1.3 Market by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hydroxyprogesterone Caproate Injection Market Size Estimates and Forecasts
2.1.1 Global Hydroxyprogesterone Caproate Injection Revenue 2020-2031
2.1.2 Global Hydroxyprogesterone Caproate Injection Sales 2020-2031
2.2 Hydroxyprogesterone Caproate Injection Market Size by Region: 2024 Versus 2031
2.3 Hydroxyprogesterone Caproate Injection Sales by Region (2020-2031)
2.3.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2020-2025
2.3.2 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Region (2026-2031)
2.3.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2031)
2.4 Hydroxyprogesterone Caproate Injection Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2020-2025
2.4.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Region (2026-2031)
2.4.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2020-2031)
3.1.1.1 Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2020-2031)
3.1.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2031)
3.1.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2031)
3.1.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2031)
3.1.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2020-2031)
3.1.3 Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2020-2031)
3.2.1.1 Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2020-2031)
3.2.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2031)
3.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2031)
3.2.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2031)
3.2.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2020-2031)
3.2.3 Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 1 mL Injection(Including 1.1 mL) of Hydroxyprogesterone Caproate Injection Revenue Market Share by Application
3.3.2 5 mL Injection of Hydroxyprogesterone Caproate Injection Revenue Market Share by Application
4 Global Hydroxyprogesterone Caproate Injection by Manufacturers
4.1 Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Sales (2020-2025)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturer (2020-2025)
4.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Revenue (2020-2025)
4.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturer (2020-2025)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturer (2020-2025)
4.3 Global Hydroxyprogesterone Caproate Injection Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Hydroxyprogesterone Caproate Injection Manufacturers Covered: Ranking by Revenue
4.4.2 Global Hydroxyprogesterone Caproate Injection Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Hydroxyprogesterone Caproate Injection Manufacturing Base Distribution, Product Type
4.5.1 Hydroxyprogesterone Caproate Injection Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Hydroxyprogesterone Caproate Injection Market
4.5.3 Manufacturers Hydroxyprogesterone Caproate Injection Product Type and Application
4.5.4 1 mL Injection(Including 1.1 mL) Market Sales of Hydroxyprogesterone Caproate Injection by Manufacturer
4.5.5 5 mL Injection Market Sales of Hydroxyprogesterone Caproate Injection by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AMAG Pharmaceuticals
5.1.1 AMAG Pharmaceuticals Company Information
5.1.2 AMAG Pharmaceuticals Description, Business Overview
5.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Products Offered
5.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales by Product in 2024
5.1.6 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales by Application in 2024
5.1.7 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales by Geographic Area in 2024
5.1.8 AMAG Pharmaceuticals Recent Developments
5.2 Mcguff Pharmaceuticals Inc
5.2.1 Mcguff Pharmaceuticals Inc Company Information
5.2.2 Mcguff Pharmaceuticals Inc Description, Business Overview
5.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Products Offered
5.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales by Product in 2024
5.2.6 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales by Application in 2024
5.2.7 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales by Geographic Area in 2024
5.2.8 Mcguff Pharmaceuticals Inc Recent Developments
5.3 Aspen Oss B.V
5.3.1 Aspen Oss B.V Company Information
5.3.2 Aspen Oss B.V Description, Business Overview
5.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Products Offered
5.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales by Product in 2024
5.3.6 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales by Application in 2024
5.3.7 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales by Geographic Area in 2024
5.3.8 Aspen Oss B.V Recent Developments
5.4 American Regent, Inc.
5.4.1 American Regent, Inc. Company Information
5.4.2 American Regent, Inc. Description, Business Overview
5.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Products Offered
5.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
5.4.5 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales by Product in 2024
5.4.6 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales by Application in 2024
5.4.7 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales by Geographic Area in 2024
5.4.8 American Regent, Inc. Recent Developments
5.5 Mylan Institutional
5.5.1 Mylan Institutional Company Information
5.5.2 Mylan Institutional Description, Business Overview
5.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Products Offered
5.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales by Product in 2024
5.5.6 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales by Application in 2024
5.5.7 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales by Geographic Area in 2024
5.5.8 Mylan Institutional Recent Developments
6 North America
6.1 North America Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2020-2031
6.2 North America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
6.2.1 North America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
6.2.2 North America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
6.3 North America Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
6.4 North America Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Market Facts & Figures by Region
7.2.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2020-2031)
7.2.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2031)
7.3 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
7.4 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
8 Europe
8.1 Europe Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2020-2031
8.2 Europe Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
8.2.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
8.2.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
8.3 Europe Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
8.4 Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2020-2031
9.2 Latin America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
9.2.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
9.2.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
9.3 Latin America Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
9.4 Latin America Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
10.2.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2031)
10.2.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2031)
10.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
10.4 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Hydroxyprogesterone Caproate Injection Supply Chain Analysis
11.2 Hydroxyprogesterone Caproate Injection Key Raw Materials and Upstream Suppliers
11.3 Hydroxyprogesterone Caproate Injection Clients Analysis
11.4 Hydroxyprogesterone Caproate Injection Sales Channel and Sales Model Analysis
11.4.1 Hydroxyprogesterone Caproate Injection Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Hydroxyprogesterone Caproate Injection Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Hydroxyprogesterone Caproate Injection Distributors
12 Hydroxyprogesterone Caproate Injection Market Dynamics
12.1 Hydroxyprogesterone Caproate Injection Industry Trends
12.2 Hydroxyprogesterone Caproate Injection Market Drivers
12.3 Hydroxyprogesterone Caproate Injection Market Challenges
12.4 Hydroxyprogesterone Caproate Injection Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V.
American Regent, Inc
Mylan Institutional
List of Tables
 Table 1. Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Hydroxyprogesterone Caproate Injection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Hydroxyprogesterone Caproate Injection Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
 Table 5. Global Hydroxyprogesterone Caproate Injection Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Hydroxyprogesterone Caproate Injection Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Hydroxyprogesterone Caproate Injection Sales Share by Manufacturer (2020-2025)
 Table 18. Hydroxyprogesterone Caproate Injection Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Hydroxyprogesterone Caproate Injection Price (2020-2025) & (US$/Unit)
 Table 21. Ranking of Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Hydroxyprogesterone Caproate Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Hydroxyprogesterone Caproate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2024)
 Table 24. Hydroxyprogesterone Caproate Injection Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Hydroxyprogesterone Caproate Injection Market
 Table 26. Manufacturers Hydroxyprogesterone Caproate Injection Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. AMAG Pharmaceuticals Company Information
 Table 29. AMAG Pharmaceuticals Description and Business Overview
 Table 30. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product
 Table 31. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 32. AMAG Pharmaceuticals Sales Proportion of Hydroxyprogesterone Caproate Injection by Product in 2024
 Table 33. AMAG Pharmaceuticals Sales Proportion of Hydroxyprogesterone Caproate Injection by Application in 2024
 Table 34. AMAG Pharmaceuticals Sales Proportion of Hydroxyprogesterone Caproate Injection by Geographic Area in 2024
 Table 35. AMAG Pharmaceuticals Recent Developments
 Table 36. Mcguff Pharmaceuticals Inc Company Information
 Table 37. Mcguff Pharmaceuticals Inc Description and Business Overview
 Table 38. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product
 Table 39. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 40. Mcguff Pharmaceuticals Inc Sales Proportion of Hydroxyprogesterone Caproate Injection by Product in 2024
 Table 41. Mcguff Pharmaceuticals Inc Sales Proportion of Hydroxyprogesterone Caproate Injection by Application in 2024
 Table 42. Mcguff Pharmaceuticals Inc Sales Proportion of Hydroxyprogesterone Caproate Injection by Geographic Area in 2024
 Table 43. Mcguff Pharmaceuticals Inc Recent Developments
 Table 44. Aspen Oss B.V Company Information
 Table 45. Aspen Oss B.V Description and Business Overview
 Table 46. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product
 Table 47. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 48. Aspen Oss B.V Sales Proportion of Hydroxyprogesterone Caproate Injection by Product in 2024
 Table 49. Aspen Oss B.V Sales Proportion of Hydroxyprogesterone Caproate Injection by Application in 2024
 Table 50. Aspen Oss B.V Sales Proportion of Hydroxyprogesterone Caproate Injection by Geographic Area in 2024
 Table 51. Aspen Oss B.V Recent Developments
 Table 52. American Regent, Inc. Company Information
 Table 53. American Regent, Inc. Description and Business Overview
 Table 54. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product
 Table 55. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 56. American Regent, Inc. Sales Proportion of Hydroxyprogesterone Caproate Injection by Product in 2024
 Table 57. American Regent, Inc. Sales Proportion of Hydroxyprogesterone Caproate Injection by Application in 2024
 Table 58. American Regent, Inc. Sales Proportion of Hydroxyprogesterone Caproate Injection by Geographic Area in 2024
 Table 59. American Regent, Inc. Recent Developments
 Table 60. Mylan Institutional Company Information
 Table 61. Mylan Institutional Description and Business Overview
 Table 62. Mylan Institutional Hydroxyprogesterone Caproate Injection Product
 Table 63. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 64. Mylan Institutional Sales Proportion of Hydroxyprogesterone Caproate Injection by Product in 2024
 Table 65. Mylan Institutional Sales Proportion of Hydroxyprogesterone Caproate Injection by Application in 2024
 Table 66. Mylan Institutional Sales Proportion of Hydroxyprogesterone Caproate Injection by Geographic Area in 2024
 Table 67. Mylan Institutional Recent Developments
 Table 68. North America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
 Table 69. North America Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
 Table 70. North America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 71. North America Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 72. North America Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025) & (K Units)
 Table 73. North America Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
 Table 74. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
 Table 75. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2026-2031) & (K Units)
 Table 76. Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 77. Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 78. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025) & (K Units)
 Table 79. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
 Table 80. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
 Table 81. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
 Table 82. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 83. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 84. Europe Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025) & (K Units)
 Table 85. Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
 Table 86. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
 Table 87. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
 Table 88. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 89. Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 90. Latin America Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025) & (K Units)
 Table 91. Latin America Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
 Table 92. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
 Table 93. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2026-2031) & (K Units)
 Table 94. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 95. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 96. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025) & (K Units)
 Table 97. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
 Table 98. Hydroxyprogesterone Caproate Injection Key Raw Materials, Industry Status and Trend
 Table 99. Hydroxyprogesterone Caproate Injection Key Raw Materials and Upstream Suppliers
 Table 100. Hydroxyprogesterone Caproate Injection Clients Status and Trend
 Table 101. Hydroxyprogesterone Caproate Injection Typical Clients
 Table 102. Hydroxyprogesterone Caproate Injection Distributors
 Table 103. Hydroxyprogesterone Caproate Injection Market Trends
 Table 104. Hydroxyprogesterone Caproate Injection Market Drivers
 Table 105. Hydroxyprogesterone Caproate Injection Market Challenges
 Table 106. Hydroxyprogesterone Caproate Injection Market Restraints
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Hydroxyprogesterone Caproate Injection Product Picture
 Figure 2. Global Hydroxyprogesterone Caproate Injection Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2024 & 2031
 Figure 4. 1 mL Injection(Including 1.1 mL) Product Picture
 Figure 5. 5 mL Injection Product Picture
 Figure 6. Global Hydroxyprogesterone Caproate Injection Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2024 & 2031
 Figure 8. Hospitals Injection
 Figure 9. Clinics Injection
 Figure 10. Hydroxyprogesterone Caproate Injection Report Years Considered
 Figure 11. Global Hydroxyprogesterone Caproate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hydroxyprogesterone Caproate Injection Market Size 2020-2031 (US$ Million)
 Figure 13. Global Hydroxyprogesterone Caproate Injection Sales 2020-2031 (K Units)
 Figure 14. Global Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2031)
 Figure 16. Global Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Hydroxyprogesterone Caproate Injection Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
 Figure 19. Global Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Hydroxyprogesterone Caproate Injection Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
 Figure 22. 1 mL Injection(Including 1.1 mL) of Hydroxyprogesterone Caproate Injection Revenue Market Share by Application, 2024 VS 2031
 Figure 23. 5 mL Injection of Hydroxyprogesterone Caproate Injection Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Hydroxyprogesterone Caproate Injection Sales Share by Manufacturer in 2024
 Figure 25. Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. 1 mL Injection(Including 1.1 mL) Market Sales Proportion by Manufacturer in 2024
 Figure 27. 5 mL Injection Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Hydroxyprogesterone Caproate Injection Revenue 2020-2031 (US$ Million)
 Figure 29. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
 Figure 30. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
 Figure 36. Europe Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
 Figure 38. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
 Figure 40. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
 Figure 51. Hydroxyprogesterone Caproate Injection Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Hydroxyprogesterone Caproate Injection Raw Materials by Region in 2024
 Figure 53. Hydroxyprogesterone Caproate Injection Distribution Channels
 Figure 54. Global Hydroxyprogesterone Caproate Injection Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Hydroxyprogesterone Caproate Injection Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Hydroxyprogesterone Caproate API Market Research Report 2024
Global Olprinone Hydrochloride Injection Market Research Report 2024
Global 17α Hydroxyprogesterone 17α OHP Market Research Report 2025
Global Leuprorelin Acetate Microspheres for Injection Market Research Report 2024
Global Progesterone Preparations Market Research Report 2024
11 Hydroxyprogesterone 11 OHP Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ganirelix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ganirelix Acetate API Market Research Report 2024
Global Ganirelix API Market Research Report 2024
Global Progesterone Drugs Market Research Report 2025
Global Polycaprolactone Diol Market Research Report 2024
Global 2 Hydroxy 2 Methylpropiophenone Photoinitiator 1173 Market Research Report 2024
Global Leuprorelin Acetate Market Insights Forecast to 2030
Global Hydroxyethyl Resorcinal HER Market Research Report 2024
Global Ganirelix Acetate Injection Market Research Report 2024
Mestranol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
PCL diol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Norethindrone Acetate API Market Research Report 2024
Global Loteprednol Etabonate API Market Research Report 2024
Global Tiopronin Powder Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions